BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

613 related articles for article (PubMed ID: 28834032)

  • 1. BK polyomavirus infection after renal transplantation: Surveillance in a resource-challenged setting.
    Bagchi S; Gopalakrishnan V; Srivastava SK; Upadhayay A; Singh G; Bhowmik D; Mahajan S; Dinda A; Agarwal SK
    Transpl Infect Dis; 2017 Dec; 19(6):. PubMed ID: 28834032
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of donor BK polyomavirus replication on recipient infections in living donor transplantation.
    Grellier J; Hirsch HH; Mengelle C; Esposito L; Hebral AL; Bellière J; Weissbach F; Izopet J; Del Bello A; Kamar N
    Transpl Infect Dis; 2018 Aug; 20(4):e12917. PubMed ID: 29800505
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stabilization of renal function after the first year of follow-up in kidney transplant recipients treated for significant BK polyomavirus infection or BK polyomavirus-associated nephropathy.
    Simard-Meilleur MC; Bodson-Clermont P; St-Louis G; Pâquet MR; Girardin C; Fortin MC; Cardinal H; Hébert MJ; Lévesque R; Renoult E
    Transpl Infect Dis; 2017 Jun; 19(3):. PubMed ID: 28207975
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Determination of viremia cut-off for risk to develop BKPyV-associated nephropathy among kidney transplant recipients.
    Bicalho CS; Oliveira RDR; David DR; Fink MCDS; Agena F; Castro MC; Panutti C; David-Neto E; Pierrotti LC
    Transpl Infect Dis; 2018 Oct; 20(5):e12969. PubMed ID: 30074295
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence of polyoma BK virus infection among living-donor renal transplant recipients.
    El Ansary M; Abd Elhamid S; Saadi G; Ismail W; Ibrahim N; Bahaa El-Din N; Alhsyek S
    Transpl Infect Dis; 2016 Aug; 18(4):529-37. PubMed ID: 27226063
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prospective monitoring of BK virus replication in renal transplant recipients.
    Koukoulaki M; Grispou E; Pistolas D; Balaska K; Apostolou T; Anagnostopoulou M; Tseleni-Kotsovili A; Hadjiconstantinou V; Paniara O; Saroglou G; Legakis N; Drakopoulos S
    Transpl Infect Dis; 2009 Feb; 11(1):1-10. PubMed ID: 18811631
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In kidney transplant recipients with BK polyomavirus infection, early BK nephropathy, microvascular inflammation, and serum creatinine are risk factors for graft loss.
    Mohamed M; Parajuli S; Muth B; Astor BC; Panzer SE; Mandelbrot D; Zhong W; Djamali A
    Transpl Infect Dis; 2016 Jun; 18(3):361-71. PubMed ID: 26998753
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incidence and outcome of BK polyomavirus infection in a multicenter randomized controlled trial with renal transplant patients receiving cyclosporine-, mycophenolate sodium-, or everolimus-based low-dose immunosuppressive therapy.
    van Doesum WB; Gard L; Bemelman FJ; de Fijter JW; Homan van der Heide JJ; Niesters HG; van Son WJ; Stegeman CA; Groen H; Riezebos-Brilman A; Sanders JSF
    Transpl Infect Dis; 2017 Jun; 19(3):. PubMed ID: 28258601
    [TBL] [Abstract][Full Text] [Related]  

  • 9. BK viremia and nephropathy in pediatric renal transplant recipients.
    Hamasaki Y; Dolan NM; Cubitt D; Breuer J; Sebire NJ; Marks SD
    Pediatr Transplant; 2019 Aug; 23(5):e13460. PubMed ID: 31273924
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The status of BK polyomavirus replication in adult renal transplant recipients in northeastern Poland.
    Naumnik B; Kowalewska J; Zalewski G; Charkiewicz R; Myśliwiec M
    Transplant Proc; 2011 Oct; 43(8):2976-84. PubMed ID: 21996205
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Isolated heart and liver transplant recipients are at low risk for polyomavirus BKV nephropathy.
    Puliyanda DP; Amet N; Dhawan A; Hilo L; Radha RK; Bunnapradist S; Czer L; Martin P; Jordan S; Toyoda M
    Clin Transplant; 2006; 20(3):289-94. PubMed ID: 16824143
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Monitoring of polyomavirus BK replication and impact of preemptive immunosuppression reduction in renal-transplant recipients in China: a 5-year single-center analysis.
    Huang G; Wang CX; Zhang L; Fei JG; Deng SX; Qiu J; Li J; Chen GD; Fu Q; Chen LZ
    Diagn Microbiol Infect Dis; 2015 Jan; 81(1):21-6. PubMed ID: 25445121
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prospective monitoring of BK virus reactivation in renal transplant recipients in North India.
    Thakur R; Arora S; Nada R; Minz M; Joshi K
    Transpl Infect Dis; 2011 Dec; 13(6):575-83. PubMed ID: 21507160
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of HMG-CoA reductase inhibitors on the incidence of polyomavirus-associated nephropathy in renal transplant recipients with human BK polyomavirus viremia.
    Gabardi S; Ramasamy S; Kim M; Klasek R; Carter D; Mackenzie MR; Chandraker A; Tan CS
    Transpl Infect Dis; 2015 Aug; 17(4):536-43. PubMed ID: 25989423
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Frequency and Associated Factors for BK Virus Infection in a Center Performing Mainly Living Kidney Transplantations.
    Alagoz S; Kuskucu M; Gulcicek S; Yalin SF; Oruc M; Midilli K; Yılmaz E; Altiparmak MR; Seyahi N
    Prog Transplant; 2017 Jun; 27(2):152-159. PubMed ID: 28617169
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluating the impact of pre-transplant desensitization utilizing a plasmapheresis and low-dose intravenous immunoglobulin protocol on BK viremia in renal transplant recipients.
    Gabardi S; Townsend K; Martin ST; Chandraker A
    Transpl Infect Dis; 2013 Aug; 15(4):361-8. PubMed ID: 23647907
    [TBL] [Abstract][Full Text] [Related]  

  • 17. BK virus nephropathy in renal transplant recipients in Kuwait: a preliminary report.
    Nampoory MR; Johny KV; Pacsa A; Nair PM; Said T; Halim MA; Francis I; Samhan M; Mousawi M; Dalawi A; Szucs G; Al-Nakib W
    Transplant Proc; 2005 Sep; 37(7):3048-50. PubMed ID: 16213300
    [TBL] [Abstract][Full Text] [Related]  

  • 18. BK viremia surveillance and outcomes in simultaneous pancreas-kidney transplant recipients.
    Westphal SG; Lyden ER; Langewisch ED; Miles CD
    Clin Transplant; 2017 Aug; 31(8):. PubMed ID: 28509373
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical characteristics and outcomes of late-onset BK virus nephropathy in kidney and kidney-pancreas transplant recipients.
    Imlay H; Whitaker K; Fisher CE; Limaye AP
    Transpl Infect Dis; 2018 Aug; 20(4):e12928. PubMed ID: 29809315
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Incidence of BK polyomavirus infection after kidney transplantation is independent of type of immunosuppressive therapy.
    Radtke J; Dietze N; Fischer L; Achilles EG; Li J; Scheidat S; Thaiss F; Nashan B; Koch M
    Transpl Infect Dis; 2016 Dec; 18(6):850-855. PubMed ID: 27639176
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.